Department of Internal Medicine I, University of Luebeck, Luebeck, Germany.
Nutr Diabetes. 2011 Sep 5;1(9):e16. doi: 10.1038/nutd.2011.12.
The endocannabinoid system is a major component in the control of energy metabolism. Cannabinoid 1 (CB1)-receptor blockade induces weight loss and reduces the risk to develop the metabolic syndrome with its associated cardiovascular complications. These effects are mediated by central and peripheral pathways. Interestingly, weight loss is mainly achieved by a reduction of visceral fat mass. We analyzed fat depot-specific differences on adipocyte differentiation, inflammation and oxidative metabolism in CB1-receptor knockout cells.
We used newly generated epididymal/inguinal adipose cell lines from CB1-receptor knockout mice. Differences in differentiation were measured by fat-specific Oil Red O staining and quantitative analysis of key differentiation markers. Induction of apoptosis was evaluated by cell death detection and investigation of p53 phosphorylation. Inflammation markers were quantified by real-time PCR. For analyzing the process of transdifferentiation we measured oxygen consumption and mitochondrial biogenesis.
Differentiation was reduced in visceral adipocytes from CB1-receptor knockout mice as compared with wild-type controls. Moreover, we found an induction of apoptosis in these cells. In contrast, subcutaneous adipocytes from CB1-receptor knockout mice showed an accelerated differentiation and a reduced rate of apoptosis. Inflammation was increased in visceral fat cells, as analyzed by the expression pattern of interleukin-6, monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor-α, whereas in subcutaneous adipocytes these markers were decreased. Furthermore, subcutaneous CB1-receptor knockout cells were more sensitive toward a conversion into a brown fat phenotype. Uncoupling protein-1 as well as PGC-1α expression was significantly elevated. This was accompanied by an increase in mitochondrial biogenesis and oxygen consumption.
In conclusion, we found depot-specific effects on differentiation, apoptosis, inflammation and oxidative metabolism in CB1-receptor knockout cells. Thus, CB1-receptor-mediated pathways differentially target adipose tissue depots to a dual effect that minimizes cardiometabolic risk, on the one hand, by diminishing visceral fat, and that enhances thermogenesis in subcutaneous adipocytes, on the other.
内源性大麻素系统是控制能量代谢的主要组成部分。大麻素 1(CB1)-受体阻断可诱导体重减轻,并降低发生代谢综合征及其相关心血管并发症的风险。这些作用是通过中枢和外周途径介导的。有趣的是,体重减轻主要是通过减少内脏脂肪量来实现的。我们分析了 CB1 受体敲除细胞中脂肪组织特异性差异对脂肪细胞分化、炎症和氧化代谢的影响。
我们使用新生成的来自 CB1 受体敲除小鼠的附睾/腹股沟脂肪细胞系。通过脂肪特异性油红 O 染色和关键分化标志物的定量分析来测量分化差异。通过细胞死亡检测和 p53 磷酸化的研究评估细胞凋亡的诱导。通过实时 PCR 定量炎症标志物。为了分析转分化过程,我们测量了耗氧量和线粒体生物发生。
与野生型对照相比,CB1 受体敲除小鼠的内脏脂肪细胞分化减少。此外,我们发现这些细胞中存在细胞凋亡的诱导。相比之下,CB1 受体敲除小鼠的皮下脂肪细胞表现出加速分化和降低的凋亡率。通过白细胞介素 6、单核细胞趋化蛋白 1(MCP-1)、肿瘤坏死因子-α的表达模式分析,发现内脏脂肪细胞的炎症增加,而皮下脂肪细胞中的这些标志物减少。此外,皮下 CB1 受体敲除细胞对转化为棕色脂肪表型更为敏感。解偶联蛋白 1 以及 PGC-1α 的表达显著升高。这伴随着线粒体生物发生和耗氧量的增加。
总之,我们发现 CB1 受体敲除细胞在分化、凋亡、炎症和氧化代谢方面存在组织特异性效应。因此,CB1 受体介导的途径通过减少内脏脂肪,对脂肪组织产生双重作用,一方面降低了心血管代谢风险,另一方面增强了皮下脂肪细胞的产热作用。